Professor of Medicine University of North Carolina at Chapel Hill Chapel Hill, NC, United States
Disclosure(s):
David van Duin, MD, PhD: Entasis: Advisor/Consultant (Terminated, August 24, 2021), Honoraria (Terminated, August 24, 2021); Merck: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); pfizer: Honoraria (Terminated, March 17, 2022); Qpex: Advisor/Consultant (Terminated, February 18, 2023); Roche: Advisor/Consultant (Ongoing); Shionogi: Advisor/Consultant (Terminated, February 16, 2023), Grant/Research Support (Terminated, February 16, 2023)